duced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.

Introduction
Three highly pathogenic human coronaviruses (CoVs) have been identified so far, including M